About KARAMEDICA, INC
Karamedica is a company focused on expanding medical and veterinary uses of biopolymer-based products, particularly chitosan, through novel decontamination processes like non-thermal plasma technology. The company aims to develop implantable hemostatic devices and drug delivery systems using these biopolymers.
Plasma treatment of chitosan and other biopolymers to lower endotoxin levelsDevelopment of implantable hemostatic devices for controlling bleeding during surgeryCreation of drug delivery vehicles for superficial bladder cancer and cerebral amyloid angiopathy (CAA)Non-thermal atmospheric pressure nitrogen plasma technology for decontamination of delicate biomaterials
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to KARAMEDICA, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.